FIGURE 2 2.1 Polyphenols Silymarin, the flavonoid extract from the Silybum marianum (L.) Gaertn
126 Using nanoparticles as carriers, targeted delivery to DON can be achieved by regulating the particle size, surface properties, and composition
Thus far, approximately 40 companies worldwide, including Codiak Biosciences, Evox Therapeutics, Tavec Pharmaceuticals, Carmine Therapeutics, Anjarium, and Micromedmark Biotech, have developed exosome-based therapies, which are expected to provide cost-effective and more accurate targeted therapies in the clinic ( However, challenges, such as large-scale production, purity, and batch homogeneity of exosomes, still limit their clinical application
Kevin M
Dlaczego badania kliniczne s tak wane To, e substancja dziaa w probwce albo u zwierzt laboratoryjnych, nie oznacza jeszcze, e bdzie skuteczna i bezpieczna u czowieka